Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Here is an official image and detailed information about Jascayd (nerandomilast), the recently approved drug for idiopathic pulmonary fibrosis (IPF): FDA Approval News: FDA Approves Jascayd Manufacturer Site: Jascayd by Boehringer Ingelheim #Pharmacy #DrugUpdate #IdiopathicPulmonaryFibrosis #FDAApproval #Jascayd #LungHealth #PharmaceuticalSciences #HealthcareInnovation To view or add a comment, sign in Explore related topics Explore content categories
R.YadegariM
Serious reactions are rare, but they happen when safety protocols slip
Public written comments can be submitted to docket FDA-2025-N-6895 through July 22, 2026
G.HoltR
Gualtieri, a senior policy advisor in the Office of Policy and Management, emailed staff at other agencies to book a meeting about the petition, including Anne Kleza, legislative and policy director in the governors office
US$ 25.40
US$ 21.00
US$ 24.98
US$ 29.14
US$ 28.46
